119 related articles for article (PubMed ID: 1899807)
1. Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.
Larsson LG; Schena M; Carlsson M; Sällström J; Nilsson K
Blood; 1991 Mar; 77(5):1025-32. PubMed ID: 1899807
[TBL] [Abstract][Full Text] [Related]
2. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.
Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR
Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
Greil R; Fasching B; Loidl P; Huber H
Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
[TBL] [Abstract][Full Text] [Related]
4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
5. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
6. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene expression in bovine peripheral blood leukemic lymphocytes during their spontaneous proliferation, differentiation and apoptosis in vitro.
Kalvelyte AV; Pabrezaite LC
Leuk Res; 1998 Feb; 22(2):135-43. PubMed ID: 9593470
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).
Mohamed AN; Mohammad RM; Koop BF; al-Katib A
Cancer; 1989 Sep; 64(5):1041-8. PubMed ID: 2527086
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
10. Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells.
Krysov S; Dias S; Paterson A; Mockridge CI; Potter KN; Smith KA; Ashton-Key M; Stevenson FK; Packham G
Blood; 2012 Jan; 119(1):170-9. PubMed ID: 22086413
[TBL] [Abstract][Full Text] [Related]
11. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA.
Carlsson M; Tötterman TH; Matsson P; Nilsson K
Blood; 1988 Feb; 71(2):415-21. PubMed ID: 3257396
[TBL] [Abstract][Full Text] [Related]
13. Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
Gibson SE; Leeman-Neill RJ; Jain S; Piao W; Cieply KM; Swerdlow SH
Br J Haematol; 2016 Oct; 175(1):173-5. PubMed ID: 26568397
[No Abstract] [Full Text] [Related]
14. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc.
Mata-Greenwood E; Cuendet M; Sher D; Gustin D; Stock W; Pezzuto JM
Leukemia; 2002 Nov; 16(11):2275-84. PubMed ID: 12399973
[TBL] [Abstract][Full Text] [Related]
15. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
16. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.
Parrado A; Noguera ME; Delmer A; McKenna S; Davies J; Le Gall I; Bentley P; Whittaker JA; Sigaux F; Chomienne C; Padua RA
Hematol J; 2000; 1(1):15-27. PubMed ID: 11920165
[TBL] [Abstract][Full Text] [Related]
18. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
19. Human B-lymphocyte precursors do not express the N-myc gene.
Wetherall NT; Vogler LB
Pathobiology; 1992; 60(2):87-92. PubMed ID: 1571096
[TBL] [Abstract][Full Text] [Related]
20. Abundance of the primary transcript and its processed product of growth-related genes in normal and leukemic cells during proliferation and differentiation.
Ferrari S; Tagliafico E; Manfredini R; Grande A; Rossi E; Zucchini P; Torelli G; Torelli U
Cancer Res; 1992 Jan; 52(1):11-6. PubMed ID: 1727370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
